Status:
UNKNOWN
The Effect of Dietary Intervention on Endothelial Glycocalyx in Psoriasis
Lead Sponsor:
University of Athens
Conditions:
Psoriasis
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The food supplement Endocalyx is considered to support the endothelial glycocalyx integrity by supplying sulfated polysaccharides, anti-oxidant enzymes and additional substrates for glycocalyx synthes...
Detailed Description
Sixty patients with psoriatic disease, who are referred to the outpatient psoriasis clinic of the Attikon University Hospital, will be randomized to receive food supplement Endocalyx (4 capsules per d...
Eligibility Criteria
Inclusion
- Caucasian patients with psoriatic disease (plaque-type psoriasis or psoriatic arthritis)
- Body mass index ≥18.5 Kg/m2
- If female, patients must be non-pregnant and non-breastfeeding
Exclusion
- History of acute coronary syndrome. Coronary artery disease will be excluded by a clinical history, examination and electrocardiogram.
- Moderate or severe valve disease
- Primary cardiomyopathies
- Chronic obstructive pulmonary disease
- Asthma
- Chronic kidney disease
- Liver failure
- Malignancies
Key Trial Info
Start Date :
November 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 30 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05184699
Start Date
November 1 2022
End Date
January 30 2024
Last Update
May 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Attikon University Hospital
Athens, Attica, Greece, 12462